Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of Hoxb2 by APL-associated PLZF protein

Abstract

The PLZF gene is translocated in a subset of all-trans-retinoic acid resistant acute promyelocytic leukaemia (APL) cases, encodes a DNA binding transcription factor and is expressed highly in haematopoietic progenitor cells as well-developing central nervous system (CNS). The spatially restricted and temporally dynamic pattern of PLZF expression in the developing CNS suggested that it might play a role in the circuitry regulating hindbrain segmentation. We have now identified a PLZF binding site (PLZF-RE) in an enhancer region of Hoxb2 that itself is required for directing high-level expression in rhombomers 3 and 5 of the developing hindbrain. The wild-type r3/r5 enhancer linked to a heterologous promoter was responsive to regulation by PLZF, and this activity was lost in variants containing a mutated PLZF-RE. Compared with the wild-type protein, the binding of the APL-associated reciprocal RARα–PLZF fusion to PLZF-RE was much stronger, suggesting that the N-terminal PLZF sequences missing from the fusion may play a role in the regulation of DNA binding. Consistent with this, the N-terminal POZ domain was required for cooperative binding of PLZF to a multimerized PLZF-RE. In the context of the r3/r5 enhancer, the PLZF-RE cooperated for PLZF binding with an additional A/T-rich motif positioned downstream of the PLZF-RE. This A/T motif was previously shown to be essential for the regulation of Hoxb2 expression in r3 and r5 in cooperation with another Krüppel-like zinc finger protein Krox 20. The presence of both the PLZF-RE and the A/T-rich motif was required for a maximal effect of PLZF on a heterologous promoter and was essential in vivo to direct the expression of a lacZ reporter in the chick neural tube. Hence, both PLZF and Krox20 cooperate with a common A/T motif in mediating in vivo activity of the Hoxb2 enhancer. Our findings indicate that Hoxb2 is a direct target for regulation by PLZF in the developing CNS and suggest that deregulation of Hox gene expression may contribute to APL pathogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Ahmad KF, Engel CK and Prive GG . (1998). Proc. Natl. Acad. Sci. USA, 95, 12123–12128.

  • Bardwell VJ and Treisman R . (1994). Genes Dev., 8, 1664–1677.

  • Barna M, Hawe N, Niswander L and Pandolfi PP . (2000). Nat. Genet., 25, 166–172.

  • Barrow JR and Capecchi MR . (1996). Development, 122, 3817–3828.

  • Borrow J, Shearman AM, Stanton Jr, VP, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J and Housman DE . (1996). Nat. Genet., 12, 159–167.

  • Braunstein M, Rose AB, Holmes SG, Allis CD and Broach JR . (1993). Genes Dev., 7, 592–604.

  • Care A, Testa U, Bassani A, Tritarelli E, Montesoro E, Samoggia P, Cianetti L and Peschle C . (1994). Mol. Cell Biol., 14, 4872–4877.

  • Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S and Zelent A . (1993b). EMBO J., 12, 1161–1167.

  • Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang ZY, Degos L, Zelent A, Waxman S and Chomienne C . (1994). Proc. Natl. Acad. Sci. USA, 91, 1178–1182.

  • Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derre J, Berger R, Waxman S and Chen Z . (1993a). J. Clin. Invest., 91, 2260–2267.

  • Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, Licht J, Waxman S, Chen Z, Gluecksohn-Waelsch S et al. (1995). Proc. Natl. Acad. Sci. USA, 92, 2249–2253.

  • Davenne M, Maconochie MK, Neun R, Pattyn A, Chambon P, Krumlauf R and Rijli FM . (1999). Neuron, 22, 677–691.

  • David G, Alland L, Hong SH, Wong CW, DePinho RA and Dejean A . (1998). Oncogene, 16, 2549–2556.

  • Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP and Leprince D . (1995). Cell Growth Differ., 6, 1495–1503.

  • Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C et al. (1996). Proc. Natl. Acad. Sci. USA, 93, 3624–3629.

  • Espinas ML, Jimenez-Garcia E, Vaquero A, Canudas S, Bernues J and Azorin F . (1999). J. Biol. Chem., 274, 16461–16469.

  • Gendron-Maguire M, Mallo M, Zhang M and Gridley T . (1993). Cell, 75, 1317–1331.

  • Giampaolo A, Sterpetti P, Bulgarini D, Samoggia P, Pelosi E, Valtieri M and Peschle C . (1994). Blood, 84, 3637–3647.

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES . (1999). Science, 286, 531–537.

  • Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S and Pelicci PG . (1998). Nature, 391, 815–818.

  • Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S and Zelent A . (1998). Blood, 91, 2634–2642.

  • He L, Bhaumik M, Tribioli C, Rego EM, Ivins S, Zelent A and Pandolfi PP . (2000). Mol. Cell, 6, 1131–1141.

  • He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP . (1998). Nat. Genet., 18, 126–135.

  • Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A and Licht J . (1999). Blood, 94, 3737–3747.

  • Hong SH, David G, Wong CW, Dejean A and Privalsky ML . (1997). Proc. Natl. Acad. Sci. USA, 94, 9028–9033.

  • Itasaki N, Bel-Vialar S and Krumlauf R . (1999). Nat. Cell Biol., 1, E203–E207.

  • Kamps MP, Murre C, Sun X-H and Baltimore D . (1990). Cell, 60, 547–555.

  • Katsani KR, Hajibagheri MA and Verrijzer CP . (1999). EMBO J., 18, 698–708.

  • Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM and Sauvageau G . (1998). EMBO J., 17, 3714–3725.

  • Li JY, English MA, Ball HJ, Yeyati PL, Waxman S and Licht JD . (1997). J. Biol. Chem., 272, 22447–22455.

  • Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller Jr, WH, et al. (1995). Blood, 85, 1083–1094.

  • Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A and Waxman S . (1996). Oncogene, 12, 323–336.

  • Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr, WH and Evans RM . (1998). Nature, 391, 811–814.

  • Look AT . (1997). Science, 278, 1059–1064.

  • Magli MC, Largman C and Lawrence HJ . (1997). J. Cell Physiol., 173, 168–177.

  • Mastrangelo IA, Courey AJ, Wall JS, Jackson SP and Hough PV . (1991). Proc. Natl. Acad. Sci. USA, 88, 5670–5674.

  • Mathews CH, Detmer K, Boncinelli E, Lawrence HJ and Largman C . (1991). Blood, 78, 2248–2252.

  • Melnick A, Ahmad KF, Arai S, Polinger A, Ball H, Borden KL, Carlile GW, Prive GG and Licht JD . (2000a). Mol. Cell Biol., 20, 6550–6567.

  • Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW and Licht JD . (2000b). Mol. Cell Biol., 20, 2075–2086.

  • Merika M and Orkin SH . (1995). Mol. Cell Biol., 15, 2437–2447.

  • Miaw SC, Choi A, Yu E, Kishikawa H and Ho IC . (2000). Immunity, 12, 323–333.

  • Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG and Shaughnessy Jr, JD, (1996). Nat. Genet., 12, 154–158.

  • Natesan S and Gilman MZ . (1993). Genes Dev., 7, 2497–2509.

  • Nordeen SK . (1988). Biotechniques, 6, 454–458.

  • Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD and Cleary ML . (1990). Cell, 60, 535–545.

  • Quaranta MT, Petrini M, Tritarelli E, Samoggia P, Care A, Bottero L, Testa U and Peschle C . (1996). J. Immunol., 157, 2462–2469.

  • Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R and Zelent A . (1995). Blood, 86, 4544–4552.

  • Rijli FM, Mark M, Lakkaraju S, Dierich A, Dolle P and Chambon P . (1993). Cell, 75, 1333–1349.

  • Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, Babinet C and Charnay P . (1993). Cell, 75, 1199–1214.

  • Schreiber E, Matthias P, Muller MM and Schaffner W . (1989). Nucleic Acids Res., 17, 6419.

  • Seyfert VL, Allman D, He Y and Staudt LM . (1996). Oncogene, 12, 2331–2342.

  • Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A and Licht JD . (1998). Mol. Cell Biol., 18, 5533–5545.

  • Sham MH, Vesque C, Nonchev S, Marshall H, Frain M, Gupta RD, Whiting J, Wilkinson D, Charnay P and Krumlauf R . (1993). Cell, 72, 183–196.

  • Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP and Calame K . (1993). Science, 262, 1889–1892.

  • Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli E and Mavilio F . (1990). Nature, 346, 763–766.

  • Sitterlin D, Tiollais P and Transy C . (1997). Oncogene, 14, 1067–1074.

  • Su W, Jackson S, Tjian R and Echols H . (1991). Genes Dev., 5, 820–826.

  • Swiatek PJ and Gridley T . (1993). Genes Dev., 7, 2071–2084.

  • Vesque C, Maconochie M, Nonchev S, Ariza-McNaughton L, Kuroiwa A, Charnay P and Krumlauf R . (1996). EMBO J., 15, 5383–5396.

  • Vieille-Grosjean I, Roullot V and Courtois G . (1992). Biochem. Biophys. Res. Commun., 183, 1124–1130.

  • Whiting J, Marshall H, Cook M, Krumlauf R, Rigby PW, Stott D and Allemann RK . (1991). Genes Dev., 5, 2048–2059.

  • Wilkinson DG . (1993). Bioessays, 15, 499–505.

  • Wong CW and Privalsky ML . (1998). J. Biol. Chem., 273, 27695–27702.

  • Yee SP and Rigby PW . (1993). Genes Dev., 7, 1277–1289.

  • Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A and Licht JD . (1999). Oncogene, 18, 925–934.

  • Yu BD, Hess JL, Horning SE, Brown GA and Korsmeyer SJ . (1995). Nature, 378, 505–508.

Download references

Acknowledgements

We are grateful to Kevin Petrie, Jon D Licht and Helen Ball for comments and discussions. This work was supported by a studentship from the Medical Research Council of Great Britain (SI), a programme grant from the Leukaemia Research Fund of Great Britain and the National Institutes of Health Grant CA59936 (AZ) and core support from the Medical Research Council and Stowers Institute for Medical Research to RK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arthur Zelent.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivins, S., Pemberton, K., Guidez, F. et al. Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 22, 3685–3697 (2003). https://doi.org/10.1038/sj.onc.1206328

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206328

Keywords

This article is cited by

Search

Quick links